Safety and Immunogenicity Study of the New dHER2 Vaccine to Treat HER2-positive Metastatic Breast Cancer

Clinical trial NCT00140738 · COMPLETED

Trial details

NCT number: NCT00140738
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms, Breast

Start date: 2005-03-10
Primary completion: 2008-09-29
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.